80 results
Page 4 of 4
6-K
EX-99.1
wsu 48nscfug2c030w9
12 Nov 20
Third Quarter Interim Statement
11:30am
6-K
EX-99.1
03hzduw2tf6jfg2qx
30 Sep 20
Current report (foreign)
11:00am
6-K
EX-99.1
62c jxf9zb6o
18 Sep 20
MorphoSys and Incyte to Host Investor Event to Discuss the Unmet
8:12am
6-K
EX-99.1
tw6vdm8ek65d6
25 Aug 20
Current report (foreign)
8:11am
6-K
EX-99.1
ddg29hopfymns3vml
7 Aug 20
MorphoSys Reports Second Quarter and First Half
12:37pm
6-K
EX-99.1
fr262jp3l7dbfheapx
5 Aug 20
Half-Year Report January – June 2020
4:18pm
6-K
EX-99.2
23xqemm6u r9k
3 Aug 20
Current report (foreign)
1:10pm
6-K
EX-99.1
g5e2cecxg1 yw9bpki
8 May 20
MorphoSys Reports First Quarter 2020 Results
6:25am
6-K
EX-99.1
tqr0emvm81d42tt46vxj
6 May 20
First Quarter Interim Statement
4:19pm
6-K
EX-99.1
vvibcn49
24 Apr 20
MorphoSys Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer
11:02am
6-K
EX-99.1
pfuyhkfnz24
27 Mar 20
Current report (foreign)
3:29pm
6-K
EX-99.1
yxn0gbai2z8z
20 Mar 20
Current report (foreign)
2:15pm
6-K
EX-99.1
4rk5us2p6 kphcnw8fe
5 Feb 20
Current report (foreign)
8:37am
6-K
EX-99.1
h85vb9myq2
12 Apr 19
Current report (foreign)
6:09am
6-K
EX-99.1
8umu1tep4jx4
21 Mar 19
Current report (foreign)
6:14am
6-K
EX-99.1
gkkv9ga 1pswj35d
15 Mar 19
2018 annual report Morphosys Engineering the Medicines of Tomorrow
6:27am
20-F
k3efqbf 2gzq4frm0jb5
13 Mar 19
Annual report (foreign)
5:13pm
6-K
EX-99.1
p5ylipoa7ql1pwjfbkry
17 May 18
Annual General Meeting of MorphoSys AG Elects New Supervisory
4:07pm